These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 6093152

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synthesis and some pharmacological properties of potent and selective antagonists of the vasopressor (V1-receptor) response to arginine-vasopressin.
    Manning M, Stoev S, Bankowski K, Misicka A, Lammek B, Wo NC, Sawyer WH.
    J Med Chem; 1992 Jan 24; 35(2):382-8. PubMed ID: 1531076
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Specificity of aversive stimulus properties of vasopressin.
    Bluthé RM, Dantzer R, Mormède P, Le Moal M.
    Psychopharmacology (Berl); 1985 Jan 24; 87(2):238-41. PubMed ID: 3931152
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Central target for the behavioural effects of vasopressin neuropeptides.
    de Wied D, Gaffori O, van Ree JM, de Jong W.
    Nature; 1985 Jan 24; 308(5956):276-8. PubMed ID: 6322010
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and some pharmacological properties of 18 potent O-alkyltyrosine-substituted antagonists of the vasopressor responses to arginine-vasopressin.
    Manning M, Lammek B, Bankowski K, Seto J, Sawyer WH.
    J Med Chem; 1985 Oct 24; 28(10):1485-91. PubMed ID: 4045923
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antagonism of effects of vasopressin (AVP) on inhibitory avoidance by a vasopressin antagonist peptide [dPtyr(Me)AVP].
    LeBrun CJ, Rigter H, Martinez JL, Koob GF, Le Moal M, Bloom FE.
    Life Sci; 1984 Oct 01; 35(14):1505-12. PubMed ID: 6482669
    [Abstract] [Full Text] [Related]

  • 15. Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin.
    Hinojosa C, Haywood JR.
    J Pharmacol Exp Ther; 1986 Aug 01; 238(2):492-6. PubMed ID: 2874211
    [Abstract] [Full Text] [Related]

  • 16. Influence of arginine vasopressin receptors and angiotensin receptor subtypes on the water intake and arterial blood pressure induced by vasopressin injected into the lateral septal area of the rat.
    Abrão Saad W, Antonio De Arruda Camargo L, Sérgio Cerri P, Simões S, Abrão Saad W, Garcia G, Izabel Gutierrez L, Guarda I, Saad Guarda R.
    Auton Neurosci; 2004 Mar 31; 111(1):66-70. PubMed ID: 15109940
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Difference between male and female rats in vasopressor response to arginine vasopressin.
    László FA, Varga C, Papp A, Pávó I, Fahrenholz F.
    Acta Physiol Hung; 1993 Mar 31; 81(2):137-45. PubMed ID: 8197870
    [Abstract] [Full Text] [Related]

  • 19. The action of centrally administered arginine vasopressin on blood pressure in the conscious rabbit.
    Martin SM, Malkinson TJ, Veale WL, Pittman QJ.
    Brain Res; 1985 Nov 25; 348(1):137-45. PubMed ID: 2933125
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.